Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-CNCT05905926ArdelyxPhase 3Enrolling by invitation2031-07Estimated
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular MelanomaNCT05907954IDEAYA BiosciencesPhase 2Active not recruiting2027-04-30Estimated
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring HemodialysisNCT05908084HUMAPhase 3Active not recruiting2027-06Estimated
Study of ALTO-300 in MDDNCT05922878Alto NeurosciencePhase 2Recruiting2026-12Estimated
Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS VaccinesNCT05925127NovavaxPhase 2, Phase 3Completed2024-05-21Actual
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late XerostomiaNCT05926765MeiraGTx, LLCPhase 2Active not recruiting2027-06Estimated
4D-150 in Patients With Diabetic Macular EdemaNCT059305614D Molecular TherapeuticsPhase 2Active not recruiting2029-02-28Estimated
A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAODNCT05933200RAREPhase 3Active not recruiting2027-08Estimated
Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model.NCT05933525IMRNPhase 2Completed2024-07-01Actual
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).NCT05935085ANABPhase 2Terminated2024-10-16Actual
Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid ArthritisNCT05942911Incannex Healthcare LtdPhase 2Terminated2024-10-28Actual
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic AtrophyNCT05949593BLTEPhase 3Active not recruiting2027-06-30Estimated
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder CancerNCT05951179Protara TherapeuticsPhase 2Recruiting2031-10Estimated
POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIUNCT05953688ALMSPhase 2Terminated2024-08-13Actual
Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast CancerNCT05954143BOLTPhase 2Terminated2024-09-20Actual
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt DiseaseNCT05956626OcugenPhase 2, Phase 3Active not recruiting2026-09-28Estimated
Refractory Chronic Cough Improvement Via NAL ER (RIVER)NCT05962151Trevi TherapeuticsPhase 2Completed2025-01-06Actual
Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus NephritisNCT05962788AUPHPhase 3Terminated2025-07-04Actual
Cough Reduction in IPF With Nalbuphine ERNCT05964335Trevi TherapeuticsPhase 2Completed2025-04-24Actual
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus ErythematosusNCT05966480ALMSPhase 2Active not recruiting2026-06-23Actual
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCEDNCT05966493Glaukos CorporationPhase 2Recruiting2025-12Estimated
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionNCT05968430MLYSPhase 3Active not recruiting2025-12-30Actual
A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)NCT05972044AXSMPhase 3Completed2025-02-07Actual
Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to RavulizumabNCT05972967Omeros CorporationPhase 2Completed2024-10-10Actual
Phase 3 Adolescent Study for SARS-CoV-2 rS Variant VaccinesNCT05973006NovavaxPhase 3Completed2024-04-01Actual
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.NCT05975060NovavaxPhase 2, Phase 3Completed2023-11-15Actual
A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).NCT05975905KROSPhase 2Terminated2025-03-05Actual
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate ThrombocytopeniaNCT05980806KPTIPhase 2Recruiting2027-06Estimated
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFNCT05983250TENXPhase 3Active not recruiting2026-06-30Actual
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney TransplantationNCT05983770Eledon PharmaceuticalsPhase 2Completed2025-09-11Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.